| Literature DB >> 17460069 |
Christoph Harms1, Katharina Albrecht, Ulrike Harms, Kerstin Seidel, Ludger Hauck, Tina Baldinger, Denise Hübner, Golo Kronenberg, Junfeng An, Karsten Ruscher, Andreas Meisel, Ulrich Dirnagl, Rüdiger von Harsdorf, Matthias Endres, Heide Hörtnagl.
Abstract
The role of glucocorticoids in the regulation of apoptosis remains incongruous. Here, we demonstrate that corticosterone protects neurons from apoptosis by a mechanism involving the cyclin-dependent kinase inhibitor p21(Waf1/Cip1). In primary cortical neurons, corticosterone leads to a dose- and Akt-kinase-dependent upregulation with enhanced phosphorylation and cytoplasmic appearance of p21(Waf1/Cip1) at Thr 145. Exposure of neurons to the neurotoxin ethylcholine aziridinium (AF64A) results in activation of caspase-3 and a dramatic loss of p21(Waf1/Cip1) preceding apoptosis in neurons. These effects of AF64A are reversed by pretreatment with corticosterone. Corticosterone-mediated upregulation of p21(Waf1/Cip1) and neuroprotection are completely abolished by glucocorticoid and mineralocorticoid receptor antagonists as well as inhibitors of PI3- and Akt-kinase. Both germline and somatically induced p21(Waf1/Cip1) deficiency abrogate the neuroprotection by corticosterone, whereas overexpression of p21(Waf1/Cip1) suffices to protect neurons from apoptosis. We identify p21(Waf1/Cip1) as a novel antiapoptotic factor for postmitotic neurons and implicate p21(Waf1/Cip1) as the molecular target of neuroprotection by high-dose glucocorticoids.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17460069 PMCID: PMC6672985 DOI: 10.1523/JNEUROSCI.5110-06.2007
Source DB: PubMed Journal: J Neurosci ISSN: 0270-6474 Impact factor: 6.167